Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | Executive V.P., Operations | June 04, 2007 | June 05, 2007 |
| ANAPTYSBIO, INCANAB · Entity 4640 | Director | January 06, 2026 | January 08, 2026 |
| First Tracks Biotherapeutics, Inc.TRAX · Entity 4696 | Director | June 15, 2026 | June 17, 2026 |
| Pfenex Inc.PFNX · Entity 146052 | Director | May 05, 2017 | May 08, 2017 |
| Sienna Biopharmaceuticals, Inc.SNNA · Entity 154554 | Director | May 30, 2019 | June 03, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date June 04, 2007 · Filed June 05, 2007
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Family Trust | 132,661 |
Reported balance
After 2007-06-04 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2007-06-04 · Exercise / conversion · Acquired 10,000 · Balance 132,661 |
| Common StockSEC Table I · non-derivative | IndirectBy Family Trust | 127,518 |
Reported balance
After 2007-06-04 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2007-06-04 · Sale · Disposed 5,143 · Balance 127,518 |
| Common StockSEC Table I · non-derivative | IndirectBy Family Trust | 117,518 |
Reported balance
After 2007-06-04 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2007-06-04 · Sale · Disposed 10,000 · Balance 117,518 |
| NQSOSEC Table II · derivative / convertible security · Conversion / exercise price $38.36 · Expires 2009-07-01 | IndirectBy Family Trust | 27,391 |
Reported balance
After 2007-06-04 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2007-06-04 · Exercise / conversion · Disposed 10,000 · Balance 27,391 F1: This option exercisable as follows: 30,000 shares on July 1, 2003; 30,000 shares on July 1, 2004; 30,000 shares on July 1, 2005; 30,000 shares on July 1, 2006; and 27,391 shares in July 1, 2007. |
| Common StockSEC Table I · non-derivative | Direct | 6,668 |
Reported balance
Holding disclosure · report date 2007-06-04 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 6,668 |
| Common StockSEC Table I · non-derivative | IndirectBy Irrevocable Trust | 1,000 |
Reported balance
Holding disclosure · report date 2007-06-04 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 1,000 |
Filing footnotes · ownership attribution and instrument terms
F1: This option exercisable as follows: 30,000 shares on July 1, 2003; 30,000 shares on July 1, 2004; 30,000 shares on July 1, 2005; 30,000 shares on July 1, 2006; and 27,391 shares in July 1, 2007.
ANAPTYSBIO, INC
Report date January 06, 2026 · Filed January 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $43.91 · Expires 2036-01-05 | Direct | 5,500 |
Reported balance
After 2026-01-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-06 · Grant · Acquired 5,500 · Balance 5,500 F1: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 4,000 |
Reported balance
After 2026-01-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-01-06 · Grant · Acquired 4,000 · Balance 4,000 F2: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F2: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F3: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
First Tracks Biotherapeutics, Inc.
Report date June 15, 2026 · Filed June 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,995 |
Reported balance
After 2026-06-15 transaction · row 1
1 source rowRow 1 · 2026-06-15 · Exercise / conversion · Acquired 6,030 · Balance 10,995 F1: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-06-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-15 · Exercise / conversion · Disposed 6,030 · Balance 0 F1: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F2: The RSUs vests as to 100% of the total RSUs on June 15, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F2: The RSUs vests as to 100% of the total RSUs on June 15, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Pfenex Inc.
Report date May 05, 2017 · Filed May 08, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.92 · Expires 2027-05-05 | Direct | 18,000 |
Reported balance
After 2017-05-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-05-05 · Grant · Acquired 18,000 · Balance 18,000 F1: One hundred percent (100%) of the shares subject to the option shall vest and become exercisable on the date of the next annual meeting of the Issuer's stockholders (the "Annual Meeting") held after May 5, 2017, subject to the reporting person's continuing service through the date of the Annual Meeting. Notwithstanding the foregoing, one hundred percent (100%) of the shares subject to the option shall vest and become exercisable as of immediately prior to a Change in Control (as such term is defined in the Issuer's 2014 Equity Incentive Plan). |
Filing footnotes · ownership attribution and instrument terms
F1: One hundred percent (100%) of the shares subject to the option shall vest and become exercisable on the date of the next annual meeting of the Issuer's stockholders (the "Annual Meeting") held after May 5, 2017, subject to the reporting person's continuing service through the date of the Annual Meeting. Notwithstanding the foregoing, one hundred percent (100%) of the shares subject to the option shall vest and become exercisable as of immediately prior to a Change in Control (as such term is defined in the Issuer's 2014 Equity Incentive Plan).
Sienna Biopharmaceuticals, Inc.
Report date May 30, 2019 · Filed June 03, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.22 · Expires 2029-05-30 | Direct | 25,000 |
Reported balance
After 2019-05-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-05-30 · Grant · Acquired 25,000 · Balance 25,000 F1: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, subject to continued service through each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, subject to continued service through each applicable vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PORTOLA PHARMACEUTICALS INC
Report date July 02, 2020 · Filed July 02, 2020
Section 16 reporting ended · disclosed 2020-07-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-07-02 transaction · row 1
1 source rowRow 1 · 2020-07-02 · Disposition to issuer · Disposed 13,194 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of May 5, 2020, by and among Portola Pharmaceuticals, Inc. (the "Issuer"), Alexion Pharmaceuticals, Inc. ("Alexion") and Odyssey Merger Sub Inc. ("Merger Sub") (the "Merger Agreement"), on July 2, 2020, Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a direct, wholly owned subsidiary of Alexion (the "Merger"). At the effective time of the Merger (the "Effective Time"), these shares were canceled in exchange for $18.00 per share in cash, without interest and subject to any applicable withholding taxes. |
| Restricted Stock UnitsSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-07-02 transaction · row 2
1 source rowRow 2 · 2020-07-02 · Disposition to issuer · Disposed 7,281 · Balance 0 F2: At the Effective Time, each restricted stock unit ("RSU") was accelerated and canceled as of immediately prior to, and contingent upon, the Effective Time, in exchange for the right to receive a cash amount equal to the product of (i) the number of shares deliverable under such RSU multiplied by (ii) $18.00. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.94 · Expires 2030-06-11 | Direct | 0 |
Reported balance
After 2020-07-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-07-02 · Disposition to issuer · Disposed 11,377 · Balance 0 F3: At the Effective Time, each of these unvested and outstanding options was accelerated, canceled and converted into the right to receive a cash amount equal to the product of (i) the number of shares that are subject to such options and (ii) $18.00 less the applicable exercise price per share of such options, subject to any applicable withholding or other taxes required by applicable law. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-07-02 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-07-02 · Disposition to issuer · Disposed 44,991 · Balance 0 F4: In connection with the Merger, these options were accelerated and canceled without payment. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of May 5, 2020, by and among Portola Pharmaceuticals, Inc. (the "Issuer"), Alexion Pharmaceuticals, Inc. ("Alexion") and Odyssey Merger Sub Inc. ("Merger Sub") (the "Merger Agreement"), on July 2, 2020, Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a direct, wholly owned subsidiary of Alexion (the "Merger"). At the effective time of the Merger (the "Effective Time"), these shares were canceled in exchange for $18.00 per share in cash, without interest and subject to any applicable withholding taxes.
F2: At the Effective Time, each restricted stock unit ("RSU") was accelerated and canceled as of immediately prior to, and contingent upon, the Effective Time, in exchange for the right to receive a cash amount equal to the product of (i) the number of shares deliverable under such RSU multiplied by (ii) $18.00.
F3: At the Effective Time, each of these unvested and outstanding options was accelerated, canceled and converted into the right to receive a cash amount equal to the product of (i) the number of shares that are subject to such options and (ii) $18.00 less the applicable exercise price per share of such options, subject to any applicable withholding or other taxes required by applicable law.
F4: In connection with the Merger, these options were accelerated and canceled without payment.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 26, 2006 Filed Oct 27, 2006 20:56 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 241 | $74.81 | $18,029.21 |
DisclosureSEC source: 0001181431-06-060052 · rrd134190.xml · nonDerivative · entry 11 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 93,771 Read SEC document |
| October 26, 2006 Filed Oct 27, 2006 20:56 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 978 | $74.80 | $73,154.40 |
DisclosureSEC source: 0001181431-06-060052 · rrd134190.xml · nonDerivative · entry 10 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 94,012 Read SEC document |
| October 26, 2006 Filed Oct 27, 2006 20:56 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 700 | $74.79 | $52,353.00 |
DisclosureSEC source: 0001181431-06-060052 · rrd134190.xml · nonDerivative · entry 9 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 94,990 Read SEC document |
| October 26, 2006 Filed Oct 27, 2006 20:56 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,008 | $74.78 | $374,498.24 |
DisclosureSEC source: 0001181431-06-060052 · rrd134190.xml · nonDerivative · entry 8 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 95,690 Read SEC document |
| October 26, 2006 Filed Oct 27, 2006 20:56 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 9,598 | $74.77 | $717,642.46 |
DisclosureSEC source: 0001181431-06-060052 · rrd134190.xml · nonDerivative · entry 7 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 100,698 Read SEC document |
| October 26, 2006 Filed Oct 27, 2006 20:56 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 10,802 | $74.76 | $807,557.52 |
DisclosureSEC source: 0001181431-06-060052 · rrd134190.xml · nonDerivative · entry 6 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 110,296 Read SEC document |
| October 26, 2006 Filed Oct 27, 2006 20:56 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 3,202 | $74.75 | $239,349.50 |
DisclosureSEC source: 0001181431-06-060052 · rrd134190.xml · nonDerivative · entry 5 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 121,098 Read SEC document |
| October 26, 2006 Filed Oct 27, 2006 20:56 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 600 | $74.74 | $44,844.00 |
DisclosureSEC source: 0001181431-06-060052 · rrd134190.xml · nonDerivative · entry 4 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 124,300 Read SEC document |
| October 26, 2006 Filed Oct 27, 2006 20:56 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 900 | $74.73 | $67,257.00 |
DisclosureSEC source: 0001181431-06-060052 · rrd134190.xml · nonDerivative · entry 3 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 124,900 Read SEC document |
| October 26, 2006 Filed Oct 27, 2006 20:56 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 40,000 | $38.36 | $1,534,400.00 |
DisclosureSEC source: 0001181431-06-060052 · rrd134190.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 125,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2006 Filed Oct 4, 2006 18:34 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionISO (Right to Buy) · Derivative | 1,621 | $61.67 Strike: $61.67 | $99,967.07 |
DisclosureSEC source: 0001181431-06-056785 · rrd132548.xml · derivative · entry 5 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,621 shares Expires 2008-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2006 Filed Oct 4, 2006 18:34 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,621 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-06-056785 · rrd132548.xml · nonDerivative · entry 3 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 85,800 F1 · kind: Transfer of shares into the Family Trust. Read SEC document |
| October 02, 2006 Filed Oct 4, 2006 18:34 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,621 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-06-056785 · rrd132548.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,334 F1 · kind: Transfer of shares into the Family Trust. Read SEC document |
| October 02, 2006 Filed Oct 4, 2006 18:34 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 1,621 | $61.67 | $99,967.07 |
DisclosureSEC source: 0001181431-06-056785 · rrd132548.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2006 Filed Jun 30, 2006 19:27 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-06-039293 · rrd123066.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 84,179 Read SEC document |
| June 01, 2006 Filed Jun 2, 2006 22:19 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 30,000 | $38.36 Strike: $38.36 | $1,150,800.00 |
DisclosureSEC source: 0001181431-06-034909 · rrd120479.xml · derivative · entry 5 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 97,391 Underlying: Common Stock · 30,000 shares Expires 2009-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2006 Filed Jun 2, 2006 22:19 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 30,000 | $68.18 | $2,045,400.00 |
DisclosureSEC source: 0001181431-06-034909 · rrd120479.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 84,279 Read SEC document |
| June 01, 2006 Filed Jun 2, 2006 22:19 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 30,000 | $38.36 | $1,150,800.00 |
DisclosureSEC source: 0001181431-06-034909 · rrd120479.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 114,279 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2006 Filed May 4, 2006 23:38 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 264 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-06-028051 · rrd116559.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 84,279 Read SEC document |
| April 03, 2006 Filed Apr 4, 2006 21:34 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 63,609 | Not disclosed Strike: $71.88 | Not disclosed |
DisclosureSEC source: 0001181431-06-022147 · rrd113346.xml · derivative · entry 5 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 63,609 Underlying: Common Stock · 63,609 shares Expires 2013-04-03 F1 · price: Right to buy granted under the Company's Amended and Restated 1991 Equity Incentive Plan. F2 · derivative.exercise_date: The option becomes exercisable annually as follows: 16,250 shares on April 3, 2007; 16,250 shares on April 3, 2008; 16,250 shares on April 3, 2009; and 14,899 shares on April 3, 2010. Read SEC document |
| April 03, 2006 Filed Apr 4, 2006 21:34 UTC | AMGEN INC AMGN · Entity 2832 | GrantISO (Right to Buy) · Derivative | 1,391 | Not disclosed Strike: $71.88 | Not disclosed |
DisclosureSEC source: 0001181431-06-022147 · rrd113346.xml · derivative · entry 4 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,391 Underlying: Common Stock · 1,391 shares Expires 2013-04-03 F1 · price: Right to buy granted under the Company's Amended and Restated 1991 Equity Incentive Plan. Read SEC document |
| March 16, 2006 Filed Mar 17, 2006 21:57 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 340 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-06-018751 · rrd111620.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 84,543 Read SEC document |
| February 24, 2006 Filed Feb 28, 2006 20:37 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 28,800 | $74.48 | $2,145,024.00 |
DisclosureSEC source: 0001181431-06-014884 · rrd109409.xml · nonDerivative · entry 4 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 84,883 Read SEC document |
| February 24, 2006 Filed Feb 28, 2006 20:37 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 8,800 | $68.19 | $600,050.00 |
DisclosureSEC source: 0001181431-06-014884 · rrd109409.xml · nonDerivative · entry 3 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 113,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2006 Filed Feb 28, 2006 20:37 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 20,000 | $38.36 | $767,200.00 |
DisclosureSEC source: 0001181431-06-014884 · rrd109409.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 104,883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2005 Filed Dec 7, 2005 22:25 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 3,049 | $79.78 | $243,249.22 |
DisclosureSEC source: 0001181431-05-065241 · rrd99350.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,951 Read SEC document |
| December 06, 2005 Filed Jan 23, 2006 19:12 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 3,617 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-06-004893 · rrd104470.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 84,883 F1 · kind: Transfer of shares into the Family Trust. Read SEC document |
| December 06, 2005 Filed Jan 23, 2006 19:12 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 3,617 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-06-004893 · rrd104470.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,334 F1 · kind: Transfer of shares into the Family Trust. Read SEC document |
| November 15, 2005 Filed Nov 17, 2005 22:44 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 82 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-062088 · rrd97381.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 81,266 Read SEC document |
| November 07, 2005 Filed Nov 9, 2005 20:35 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 25,000 | $68.19 Strike: $68.19 | $1,704,687.50 |
DisclosureSEC source: 0001181431-05-060499 · rrd96564.xml · derivative · entry 5 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 8,800 Underlying: Common Stock · 25,000 shares Expires 2007-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2005 Filed Nov 9, 2005 20:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 25,000 | $80.00 | $2,000,000.00 |
DisclosureSEC source: 0001181431-05-060499 · rrd96564.xml · nonDerivative · entry 3 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 81,348 Read SEC document |
| November 07, 2005 Filed Nov 9, 2005 20:35 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 25,000 | $68.19 | $1,704,687.50 |
DisclosureSEC source: 0001181431-05-060499 · rrd96564.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 106,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2005 Filed Aug 10, 2005 21:30 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionISO (Right to Buy) · Derivative | 1,459 | $68.50 Strike: $68.50 | $99,941.50 |
DisclosureSEC source: 0001181431-05-045839 · rrd88948.xml · derivative · entry 7 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,459 shares Expires 2007-07-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2005 Filed Aug 10, 2005 21:30 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionISO (Right to Buy) · Derivative | 1 | $38.36 Strike: $38.36 | $38.36 |
DisclosureSEC source: 0001181431-05-045839 · rrd88948.xml · derivative · entry 6 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,606 Underlying: Common Stock · 1 shares Expires 2009-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2005 Filed Aug 10, 2005 21:30 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-045839 · rrd88948.xml · nonDerivative · entry 4 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 81,348 F1 · kind: Transfer of shares into the Family Trust. Read SEC document |
| August 10, 2005 Filed Aug 10, 2005 21:30 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-045839 · rrd88948.xml · nonDerivative · entry 3 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · kind: Transfer of shares into the Family Trust. Read SEC document |
| August 10, 2005 Filed Aug 10, 2005 21:30 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 1,459 | $68.50 | $99,941.50 |
DisclosureSEC source: 0001181431-05-045839 · rrd88948.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,460 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2005 Filed Aug 10, 2005 21:30 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 1 | $38.36 | $38.36 |
DisclosureSEC source: 0001181431-05-045839 · rrd88948.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 25, 2005 Filed Jul 26, 2005 20:42 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 46,848 | $30.44 Strike: $30.44 | $1,425,936.00 |
DisclosureSEC source: 0001181431-05-042088 · rrd86841.xml · derivative · entry 5 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 0 Underlying: Common Stock · 46,848 shares Expires 2006-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: (DMF-07/99-NQSO) The option becomes exercisable for 16,026 shares on July 1, 2000, July 1,2001,July1, 2002 and July 1, 2003, respectively; and for 12,744 shares on July 1, 2004. Read SEC document |
| July 25, 2005 Filed Jul 26, 2005 20:42 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 46,848 | $81.03 | $3,795,929.47 |
DisclosureSEC source: 0001181431-05-042088 · rrd86841.xml · nonDerivative · entry 3 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 79,888 Read SEC document |
| July 25, 2005 Filed Jul 26, 2005 20:42 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 46,848 | $30.44 | $1,425,936.00 |
DisclosureSEC source: 0001181431-05-042088 · rrd86841.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 126,736 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2005 Filed Jun 6, 2005 17:02 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 27,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-033166 · rrd81448.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Executive V.P., Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 79,888 Read SEC document |
| May 23, 2005 Filed May 24, 2005 23:52 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001181431-05-030315 · rrd80058.xml · derivative · entry 5 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 46,848 Underlying: Common Stock · 30,000 shares Expires 2006-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2005 Filed May 24, 2005 23:52 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 30,000 | $61.57 | $1,847,100.00 |
DisclosureSEC source: 0001181431-05-030315 · rrd80058.xml · nonDerivative · entry 3 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 107,587 Read SEC document |
| May 23, 2005 Filed May 24, 2005 23:52 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 30,000 | $30.44 | $913,125.00 |
DisclosureSEC source: 0001181431-05-030315 · rrd80058.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 137,587 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2005 Filed Mar 17, 2005 00:52 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $58.61 | $0.00 |
DisclosureSEC source: 0001181431-05-017357 · rrd72668.xml · derivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2012-03-15 F1 · derivative.exercise_date: (03.15.05) The option becomes exercisable annually in four equal installments beginning on March 15, 2006. Read SEC document |
| February 04, 2005 Filed Feb 7, 2005 17:33 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 27,896 | $0.00 Strike: $16.38 | $0.00 |
DisclosureSEC source: 0001181431-05-007442 · rrd67512.xml · derivative · entry 3 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 0 Underlying: Common Stock · 27,896 shares Expires 2005-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2005 Filed Feb 7, 2005 17:33 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 27,896 | $62.57 | $1,745,494.56 |
DisclosureSEC source: 0001181431-05-007442 · rrd67512.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 107,587 F1 · balance_after: (DMF 1/05) Does not include (i) 20,000 shares of Amgen Inc. Common Stock directly held by the reporting person and (ii) 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| February 04, 2005 Filed Feb 7, 2005 17:33 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 27,896 | $16.38 | $456,797.00 |
DisclosureSEC source: 0001181431-05-007442 · rrd67512.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 135,483 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (DMF 1/05) Does not include (i) 20,000 shares of Amgen Inc. Common Stock directly held by the reporting person and (ii) 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| January 31, 2005 Filed Feb 1, 2005 17:37 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 165 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-005945 · rrd66710.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 107,587 F1 · balance_after: (DMF 1/05) Does not include (i) 20,000 shares of Amgen Inc. Common Stock directly held by the reporting person and (ii) 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.